LAVA Therapeutics N.V. announced Ed Smith, chief financial officer has resigned to pursue other interests, effective as of May 17, 2022. He may serve in a consulting capacity to support the Company's transition. The Company has commenced a search for Mr. Smith's permanent replacement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.64 USD | -2.94% | -4.35% | +67.09% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.09% | 71.51M | |
+64.92% | 62.59B | |
-1.85% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.96% | 19.09B | |
+4.21% | 13.08B | |
+25.74% | 12.26B | |
+27.42% | 12.05B |
- Stock Market
- Equities
- LVTX Stock
- News LAVA Therapeutics N.V.
- LAVA Therapeutics N.V. Announces the Resignation of Ed Smith as Chief Financial Officer